Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:12 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1945–1968 of 2,691 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Normal saline solution Clear all

Conditions: Pain, Postoperative
Interventions: Pain Scale, Exparel Injectable Product, Bupivacaine Injection; Other · Drug
Lead sponsor: Ochsner Health System; Other
Eligibility: 18 Years to 75 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Respiratory Syncytial Virus
Interventions: mRNA-1345, Placebo; Biological · Drug
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 12 Months to 79 Years
Enrollment: 651 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 31
States / cities: La Mesa, California • West Hollywood, California • DeLand, Florida + 28 more

Conditions: Healthy Volunteer
Interventions: TRL1068, a human monoclonal antibody; Drug
Lead sponsor: Trellis Bioscience LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: ACL Repair, Meniscectomy, Bankart Repair
Interventions: Bupivacaine; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 11 Years to 19 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Respiratory Syncytial Virus, Human Metapneumovirus
Interventions: mRNA-1345, mRNA-1365, Placebo, Nimenrix; Biological · Drug
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 5 Months to 24 Months
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 12
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Melrose Park, Illinois + 8 more

Conditions: Septic Shock, Hypotension, Tachycardia
Interventions: Esmolol, Saline; Drug · Other
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ovarian Cancer, Uterine Cancer
Interventions: fosaprepitant, aprepitant, Oral Placebo, IV placebo; Drug · Other
Lead sponsor: Gynecologic Oncology Associates; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Bone Loss, Aging
Interventions: placebo, denosumab; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 25 Years to 80 Years · Female only
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Long COVID, Long Coronavirus Disease 2019 (Covid19), Long Covid-19
Interventions: IVIG (intravenous immunoglobulin), IVIG Placebo, Coordinated Care, Usual Care; Drug · Behavioral
Lead sponsor: Kanecia Obie Zimmerman; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cancer and Chemotherapy Related Anemia
Interventions: Injectafer, Normal Saline; Drug · Other
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 244 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 29
States / cities: Corona, California • Fountain Valley, California • Riverside, California + 23 more

Conditions: Volunteers, Healthy
Interventions: Recombinant human plasma gelsolin, placebo; Drug · Other
Lead sponsor: BioAegis Therapeutics Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Papulopustular Rosacea
Interventions: Cromolyn Sodium, Normal Saline; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: San Diego, California

Conditions: Wound Healing, Surgical Wound
Interventions: RhPDGF-BB, Saline; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 22 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Post Surgical Pain
Interventions: Bupivacaine 0.25%, Dexamethasone, normal saline; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 70 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Rib Fractures
Interventions: Ropivacaine, Normal Saline Flush, 0.9% Injectable Solution; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Benign Prostatic Hyperplasia, Localized Prostate Cancer
Interventions: Robotic Waterjet Treatment; Device
Lead sponsor: PROCEPT BioRobotics; Industry
Eligibility: Up to 80 Years · Male only
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: La Mesa, California • Glenview, Illinois • Alexandria, Virginia

Conditions: Acute Antibody-Mediated Rejection (AMR)
Interventions: Cinryze®, Placebo; Biological · Drug
Lead sponsor: Shire; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 29
States / cities: Los Angeles, California • San Francisco, California • Aurora, Colorado + 22 more

Conditions: Autism Spectrum Disorders
Interventions: Suramin, Saline; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 4 Years to 17 Years · Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Osteoarthritis, Hip
Interventions: FX006, Normal saline; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 32
States / cities: Phoenix, Arizona • Tucson, Arizona • Canoga Park, California + 27 more

Conditions: Pain, Postoperative
Interventions: Exparel, Interscalene Nerve Block; Drug · Procedure
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Peri-implantitis
Interventions: Resective surgery with implantoplasty, Resective surgery with mechanical debridement; Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Rapid Atrial Fibrillation, Heart Rate Control
Interventions: Dexmedetomidine Hydrochloride, Normal Saline; Drug · Other
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Healthy Volunteers
Interventions: Lanadelumab, Placebo; Drug · Other
Lead sponsor: Takeda; Industry
Eligibility: 19 Years to 55 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Wounds and Injuries, Respiratory Failure, Pneumonia, Ventilator-Associated
Interventions: Chlorhexidine gluconate; Drug
Lead sponsor: Nicholas M Mohr; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Iowa City, Iowa

Search by objective public record fields.

Modified TAP (Transverse Abdominis Plane) Block in Colorectal Surgery

A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive

Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy Volunteers

Efficacy Study of Continuous Intraarticular Infusion in Patients Undergoing Arthroscopic Knee and Shoulder Operations

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

Esmolol to Treat the Hemodynamic Effects of Septic Shock

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Osteoclast Inhibition and Bone Formation

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)

Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®

A Study to Evaluate Plasma Gelsolin in Healthy Volunteers

An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema

Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction

Dose Response Study of Dexamethasone in Combination With Bupivacaine 0.25%

The Erector Spinae Plane Block and Its Effect on Respiratory Status and Pain Management in Rib Fracture Patients

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant

University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Liposomal Bupivacaine Versus Interscalene Nerve Block

Peri-implantitis Management: Surgical and Maintenance Outcomes

Controlling Rapid Atrial Fibrillation With Dexmedetomidine

A Study to Determine the Safety, Tolerability, and Pharmacokinetics of Lanadelumab Administered Intravenously in Healthy Adult Volunteer Participants

Prehospital Ventilator-Associated Pneumonia Prevention Trial